4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0001193125-25-267548
See Remarks sold 5,000 shares at $73.65 ($368,245)
- See Remarks acquired 5,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lyon Joseph Douglas See Remarks | 2025-11-03 | Option exercise 10b5-1 | +5,000 | $13.56 | $67,800 | 15,277 | D: show line 1 in the form |
| Lyon Joseph Douglas See Remarks | 2025-11-03 | Sale 10b5-1 | −5,000 | $73.65 | $368,245 | 10,277 | D: show line 2 in the form |
| Open-market sales · 5,000 sh · avg $73.65 · $368,245 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Lyon Joseph Douglas See Remarks | 2025-11-03 | Option exercise · Stock option (right to buy) 10b5-1 | −5,000 | 16,571 | D: show line 3 in the form |
Loading xslF345X05/ownership.xml…